{"id":"pilocarpine-hcl","safety":{"commonSideEffects":[{"rate":null,"effect":"Increased sweating"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Urinary frequency"},{"rate":null,"effect":"Lacrimation"}]},"_chembl":{"chemblId":"CHEMBL1213136","moleculeType":"Small molecule","molecularWeight":"271.27"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Pilocarpine binds to and activates muscarinic M3 receptors on salivary and lacrimal glands, mimicking the effects of acetylcholine and promoting fluid secretion. This mechanism is used to treat xerostomia (dry mouth) and xerophthalmia (dry eyes) by directly stimulating residual gland function. The drug's parasympathomimetic effects increase both salivary flow and tear production.","oneSentence":"Pilocarpine HCl is a muscarinic acetylcholine receptor agonist that stimulates parasympathetic activity to increase salivary and lacrimal gland secretion.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:26:12.478Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Xerostomia (dry mouth) in patients with Sjögren's syndrome"},{"name":"Xerophthalmia (dry eyes)"},{"name":"Radiation-induced xerostomia"}]},"trialDetails":[{"nctId":"NCT05646719","phase":"PHASE3","title":"Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia","status":"COMPLETED","sponsor":"Ocuphire Pharma, Inc.","startDate":"2022-12-22","conditions":"Presbyopia","enrollment":333},{"nctId":"NCT07414810","phase":"NA","title":"Novel Point-of-care Sweat Chloride Testing Device for Monitoring CFTR Function","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-08","conditions":"Cystic Fibrosis","enrollment":300},{"nctId":"NCT03933631","phase":"PHASE3","title":"Pilocarpine Use After Kahook Goniotomy","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2019-05-01","conditions":"Glaucoma","enrollment":142},{"nctId":"NCT04675151","phase":"PHASE2","title":"Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia","status":"COMPLETED","sponsor":"Ocuphire Pharma, Inc.","startDate":"2021-02-15","conditions":"Presbyopia","enrollment":150},{"nctId":"NCT03798223","phase":"NA","title":"Optimal Treatment Protocol for Selective Laser Trabeculoplasty","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vastra Gotaland Region","startDate":"2019-01-10","conditions":"Glaucoma, Open-Angle, Pseudoexfoliation Glaucoma, Ocular Hypertension","enrollment":400},{"nctId":"NCT05159960","phase":"NA","title":"Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial","status":"ENROLLING_BY_INVITATION","sponsor":"Vastra Gotaland Region","startDate":"2022-01-10","conditions":"Glaucoma, Open-Angle, Pseudoexfoliation Glaucoma, Ocular Hypertension","enrollment":400},{"nctId":"NCT06783686","phase":"EARLY_PHASE1","title":"Evaluation of NV701 (Pilocarpine 1.25%) Compared With Vuity (Pilocarpine 1.25%) on Pupil Size in Subjects With Presbyopia","status":"COMPLETED","sponsor":"Novus Vision LLC","startDate":"2025-01-30","conditions":"Pupil Constriction","enrollment":55},{"nctId":"NCT07113210","phase":"PHASE4","title":"Quality of Life in Presbyopic Patients Who Are Treated With Qlosi","status":"RECRUITING","sponsor":"Southern College of Optometry","startDate":"2025-07-18","conditions":"Presbyopia, Glasses, Dry Eye","enrollment":36},{"nctId":"NCT07047664","phase":"NA","title":"KERMIT: Sweat Patch for Early Kidney Disease Detection","status":"NOT_YET_RECRUITING","sponsor":"University of Ioannina","startDate":"2025-07-01","conditions":"Chronic Kidney Disease (CKD)","enrollment":52},{"nctId":"NCT07012512","phase":"NA","title":"Adjusted Study Protocol: Within-Subject Paired-Eye Design Comparing Pilocarpine 0.1%, Phentolamine 0.75%, and Combination Therapy for Cyclopentolate Reversal in Children","status":"NOT_YET_RECRUITING","sponsor":"Mansoura University","startDate":"2025-06-01","conditions":"Pupillary Constriction, Accomodation","enrollment":60},{"nctId":"NCT06752278","phase":"NA","title":"Efficacy of Pilocarpine As a Secretagogue Versus Artificial Tears for the Treatment of Dry Eye","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2024-10-01","conditions":"Dry Eye Disease (DED)","enrollment":40},{"nctId":"NCT04837482","phase":"PHASE3","title":"A Study to Assess the Impact and Adverse Events of Topical Eyedrops of AGN-190584 on Night-driving Performance in Participants, 40 to 55 Years of Age","status":"COMPLETED","sponsor":"AbbVie","startDate":"2021-05-14","conditions":"Presbyopia","enrollment":43},{"nctId":"NCT06522789","phase":"NA","title":"Preoperative Corneal Measurements Estimate the Corrected Distance Visual Acuity After Corneal Cross-linking","status":"COMPLETED","sponsor":"Sistina Ophthalmology Hospital","startDate":"2018-04-01","conditions":"Keratoconus","enrollment":124},{"nctId":"NCT06451666","phase":"PHASE3","title":"Safety and Efficacy Study of Pilocarpine HCl Ophthalmic Solution in Participants With Presbyopia","status":"NOT_YET_RECRUITING","sponsor":"CSPC Ouyi Pharmaceutical Co., Ltd.","startDate":"2024-06-30","conditions":"Presbyopia","enrollment":330},{"nctId":"NCT06354842","phase":"","title":"Measurement of Sweat Sodium Concentration in Patients With Chronic Kidney Disease","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2018-10-05","conditions":"Chronic Kidney Diseases","enrollment":64},{"nctId":"NCT04599972","phase":"PHASE3","title":"An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2)","status":"COMPLETED","sponsor":"Orasis Pharmaceuticals Ltd.","startDate":"2020-10-26","conditions":"Presbyopia","enrollment":304},{"nctId":"NCT04599933","phase":"PHASE3","title":"An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-1)","status":"COMPLETED","sponsor":"Orasis Pharmaceuticals Ltd.","startDate":"2020-10-18","conditions":"Presbyopia","enrollment":309},{"nctId":"NCT00762645","phase":"PHASE4","title":"Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG)","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2007-02","conditions":"Angle-closure Glaucoma","enrollment":30},{"nctId":"NCT04085094","phase":"","title":"Gender Differences in Renal Functioning and Disease","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2017-05-30","conditions":"Chronic Renal Failure, Healthy Controls","enrollment":98},{"nctId":"NCT05114486","phase":"PHASE3","title":"Safety & Efficacy of Pilocarpine Ophthalmic Spray for Temporary Improvement of Near Vision in Presbyopic Adults","status":"COMPLETED","sponsor":"Eyenovia Inc.","startDate":"2021-11-03","conditions":"Presbyopia","enrollment":145},{"nctId":"NCT05124275","phase":"PHASE2","title":"Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia","status":"COMPLETED","sponsor":"Glaukos Corporation","startDate":"2022-01-03","conditions":"Presbyopia","enrollment":123},{"nctId":"NCT05119920","phase":"PHASE2","title":"Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease","status":"COMPLETED","sponsor":"Glaukos Corporation","startDate":"2022-01-03","conditions":"Dry Eye Disease, Kerato Conjunctivitis Sicca","enrollment":226},{"nctId":"NCT04732195","phase":"NA","title":"Pilocarpine Microneedles for Sweat Induction (PMN-SI)","status":"COMPLETED","sponsor":"Emory University","startDate":"2022-01-20","conditions":"Cystic Fibrosis","enrollment":50},{"nctId":"NCT04741919","phase":"NA","title":"Superior vs Temporal Laser Peripheral Iridotomy in Primary Angle Closure Suspects (PACS)","status":"UNKNOWN","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2020-11-25","conditions":"Primary Angle Glaucoma Closure Suspect","enrollment":200},{"nctId":"NCT05209555","phase":"","title":"Preoperative BAMCOG and Cortisol and Postoperative DeltaScan in AVR Patients (Aortic Valve Replacement)","status":"COMPLETED","sponsor":"Catharina Ziekenhuis Eindhoven","startDate":"2022-01-10","conditions":"Delirium, Cognitive Impairment, Cognitive Dysfunction","enrollment":50},{"nctId":"NCT04983589","phase":"PHASE3","title":"A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily","status":"COMPLETED","sponsor":"Allergan","startDate":"2021-09-02","conditions":"Presbyopia","enrollment":230},{"nctId":"NCT05238233","phase":"PHASE4","title":"Wearing-Off Period of Pharmacological Dilation and Anisocoria","status":"COMPLETED","sponsor":"Prisma Health-Upstate","startDate":"2022-04-01","conditions":"Anisocoria","enrollment":11},{"nctId":"NCT05578001","phase":"PHASE3","title":"Efficacy of Pilocarpine 1% in Presbyopia","status":"UNKNOWN","sponsor":"Isfahan University of Medical Sciences","startDate":"2022-07-01","conditions":"Presbyopia, Pseudophakia","enrollment":25},{"nctId":"NCT05564832","phase":"EARLY_PHASE1","title":"Pharmacological Treatment of Presbyopia","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2022-08-01","conditions":"Near Vision","enrollment":75},{"nctId":"NCT05506137","phase":"PHASE3","title":"Xerostomia in Patients With a Life-limiting Condition or Frailty","status":"UNKNOWN","sponsor":"Maastricht University Medical Center","startDate":"2023-01","conditions":"Xerostomia, Dry Mouth","enrollment":120},{"nctId":"NCT05231928","phase":"NA","title":"A Novel Argon Laser Iridoplasty for Pigment Dispersion Syndrome","status":"UNKNOWN","sponsor":"Fayoum University","startDate":"2021-12-01","conditions":"Pigment Dispersion Syndrome, Pigmentary Glaucoma","enrollment":10},{"nctId":"NCT05393089","phase":"PHASE2","title":"Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopia","status":"WITHDRAWN","sponsor":"Allergan","startDate":"2022-06-09","conditions":"Presbyopia","enrollment":""},{"nctId":"NCT05352854","phase":"NA","title":"Morphological Changes of Ciliary Body and Trabecular Meshwork","status":"UNKNOWN","sponsor":"Yune Zhao","startDate":"2022-05-01","conditions":"Glaucoma, Myopia","enrollment":120},{"nctId":"NCT04005079","phase":"PHASE3","title":"Pilocarpine After Combined Cataract/Trabectome Surgery","status":"WITHDRAWN","sponsor":"Montefiore Medical Center","startDate":"2019-06-05","conditions":"Open Angle Glaucoma, Ocular Hypertension","enrollment":""},{"nctId":"NCT02865473","phase":"NA","title":"Anterior Segment Imaging With Ultrahigh-resolution OCT in Patients With Glaucoma and PEX - a Pilot Study","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2016-04-20","conditions":"Glaucoma","enrollment":90},{"nctId":"NCT04503252","phase":"","title":"Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2020-01-14","conditions":"Staphylococcus Aureus Infection","enrollment":50},{"nctId":"NCT05241938","phase":"NA","title":"PSLT Compared to Prostaglandin Analogue Eye Drops","status":"UNKNOWN","sponsor":"Federal University of Rio Grande do Sul","startDate":"2021-09-01","conditions":"Open Angle Glaucoma, Ocular Hypertension","enrollment":75},{"nctId":"NCT03857542","phase":"PHASE3","title":"A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia","status":"COMPLETED","sponsor":"Allergan","startDate":"2019-03-01","conditions":"Presbyopia","enrollment":427},{"nctId":"NCT03804268","phase":"PHASE3","title":"Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia","status":"COMPLETED","sponsor":"Allergan","startDate":"2018-12-21","conditions":"Presbyopia","enrollment":323},{"nctId":"NCT05006898","phase":"PHASE1","title":"Compound to Control Presbyopia Symptoms","status":"COMPLETED","sponsor":"Optall Vision","startDate":"2020-06-01","conditions":"Presbyopia","enrollment":11},{"nctId":"NCT05001243","phase":"PHASE1","title":"Comparison of a Compound With Pilocarpine and Brimonidine to Improve Near Vision in Healthy Presbyopic Patients","status":"UNKNOWN","sponsor":"Optall Vision","startDate":"2021-08-10","conditions":"Presbyopia","enrollment":11},{"nctId":"NCT05006911","phase":"PHASE1","title":"Pilocarpine, Brimonidine, Oxymetazoline (PBO) Compound to Control Presbyopia Symptoms","status":"UNKNOWN","sponsor":"Optall Vision","startDate":"2021-08-14","conditions":"Presbyopia","enrollment":11},{"nctId":"NCT04657172","phase":"PHASE3","title":"Safety & Efficacy of Pilocarpine Eye Solutions for Temporary Improvement of Near Vision in Presbyopic Adults","status":"COMPLETED","sponsor":"Eyenovia Inc.","startDate":"2020-12-15","conditions":"Presbyopia","enrollment":84},{"nctId":"NCT03584841","phase":"NA","title":"Implementation of a Non-invasive Version of the Imaging β-adrenergic-dependent Sweat Secretion Test","status":"UNKNOWN","sponsor":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","startDate":"2017-03-31","conditions":"Mucoviscidosis Involving the Lung","enrollment":120},{"nctId":"NCT04470479","phase":"PHASE3","title":"Oral Pilocarpine in the Treatment of the Dry Eye of Patients With Sjogrens Syndrome","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2005-03-01","conditions":"Dry Eye","enrollment":32},{"nctId":"NCT03460964","phase":"NA","title":"Measuring Sweat Glucose of Patients With Diabetes - The ENGAGE Study","status":"TERMINATED","sponsor":"University of California, San Diego","startDate":"2018-05-01","conditions":"Diabetes Mellitus","enrollment":2},{"nctId":"NCT00003686","phase":"PHASE3","title":"Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids","status":"TERMINATED","sponsor":"NCIC Clinical Trials Group","startDate":"1998-05-22","conditions":"Oral Complications, Quality of Life","enrollment":4},{"nctId":"NCT04195100","phase":"EARLY_PHASE1","title":"Local Pilocarpine for Relieving Dry Mouth","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2019-04-01","conditions":"Patients of Advanced Age (≥ 70 Years) With a Clinical Diagnosis of Chronic Dry Mouth","enrollment":14},{"nctId":"NCT00656513","phase":"PHASE2, PHASE3","title":"Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"2008-09","conditions":"Head and Neck Cancer, Xerostomia","enrollment":196},{"nctId":"NCT02754570","phase":"NA","title":"The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2016-07","conditions":"Glaucoma, Open-angle, Hypertension, Ocular","enrollment":27},{"nctId":"NCT03825081","phase":"EARLY_PHASE1","title":"Pilocarpine and Brimonidine in Patients With Monofocal Lenses","status":"UNKNOWN","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2019-01-21","conditions":"Presbyopia, Pseudophakia","enrollment":33},{"nctId":"NCT02310789","phase":"NA","title":"(Study: Vertex IIS) Does Ivacaftor Alter Wild Type CFTR-Open Probability In The Sweat Gland Secretory Coil?","status":"COMPLETED","sponsor":"Richard Barry Moss","startDate":"2015-07-31","conditions":"Cystic Fibrosis","enrollment":8},{"nctId":"NCT03753009","phase":"","title":"Iontophoretic Transepithelial Collagen Cross-linking Versus Epithelium-off Collagen Cross-linking in Pediatric Patients. Three Year Follow up.","status":"COMPLETED","sponsor":"Bambino Gesù Hospital and Research Institute","startDate":"2013-01-01","conditions":"Keratoconus","enrollment":28},{"nctId":"NCT02613013","phase":"NA","title":"Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2015-10","conditions":"Glaucoma, Angle-Closure","enrollment":240},{"nctId":"NCT01690052","phase":"NA","title":"Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva","status":"COMPLETED","sponsor":"University of Kentucky","startDate":"2009-01","conditions":"Dry Mouth","enrollment":15},{"nctId":"NCT02935894","phase":"NA","title":"Investigating the Stability, Variability and Mechanism of Incorporation of Lipid Mediators Into Eccrine Sweat","status":"COMPLETED","sponsor":"USDA, Western Human Nutrition Research Center","startDate":"2016-11-28","conditions":"Stability & Variability of Lipid-derived Molecules in Sweat","enrollment":14},{"nctId":"NCT00601211","phase":"NA","title":"Bioequivalency Study of 5 mg Piolocarpine Tablets Under Fed Conditions","status":"COMPLETED","sponsor":"Roxane Laboratories","startDate":"2003-09","conditions":"Dry Mouth","enrollment":28},{"nctId":"NCT00601874","phase":"NA","title":"Bioequivalency Study of 5 mg Pilocarpine Tablets Under Fasting Conditions","status":"COMPLETED","sponsor":"Roxane Laboratories","startDate":"2003-09","conditions":"Dry Mouth","enrollment":28},{"nctId":"NCT00602524","phase":"NA","title":"Bioequivalency Study of 7.5 mg Pilocarpine Tablets Under Fasting Conditions","status":"COMPLETED","sponsor":"Roxane Laboratories","startDate":"2004-08","conditions":"Dry Mouth","enrollment":28},{"nctId":"NCT00618059","phase":"NA","title":"Bioequivalency Study of 7.5 mg Pilocarpine Under Fed Conditions","status":"COMPLETED","sponsor":"Roxane Laboratories","startDate":"2004-08","conditions":"Dry Mouth","enrollment":28},{"nctId":"NCT02485067","phase":"PHASE3","title":"Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB","status":"COMPLETED","sponsor":"SK Chemicals Co., Ltd.","startDate":"2015-01","conditions":"Overactive Bladder","enrollment":384},{"nctId":"NCT02982577","phase":"PHASE4","title":"Effect of Pilocarpine in Patients With Xerostomia","status":"UNKNOWN","sponsor":"University of Sao Paulo","startDate":"2016-04","conditions":"Xerostomia","enrollment":80},{"nctId":"NCT00803803","phase":"PHASE4","title":"Dose, Effects and Characteristics of Pilocarpine","status":"COMPLETED","sponsor":"Wills Eye","startDate":"1978-08","conditions":"Open-angle Glaucoma","enrollment":37},{"nctId":"NCT00343382","phase":"PHASE3","title":"Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2006-12","conditions":"Breast Cancer, Vaginal Dryness","enrollment":201},{"nctId":"NCT02420782","phase":"PHASE1","title":"First-in-human: Single Ascending Dose, Food Effect, Drug-drug Interaction, Multiple Ascending Dose, Proof of Pharmacology","status":"COMPLETED","sponsor":"Astellas Pharma Europe B.V.","startDate":"2015-05","conditions":"Healthy Volunteers","enrollment":116},{"nctId":"NCT01036035","phase":"PHASE1","title":"Effects of Novel Combinations of Tolterodine/Pilocarpine on Pharmacokinetics (PK) and Pharmacodynamics (PD) of Tolterodine in Healthy Subjects","status":"COMPLETED","sponsor":"TheraVida, Inc.","startDate":"2009-09","conditions":"Incontinence","enrollment":18},{"nctId":"NCT00003139","phase":"PHASE3","title":"Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"1998-03","conditions":"Head and Neck Cancer, Oral Complications","enrollment":249},{"nctId":"NCT02447315","phase":"PHASE1","title":"A Study to Investigate the Effect of Oral Doses of Pilocarpine on Salivary Secretion and Static Pupillometry in Healthy Subjects","status":"COMPLETED","sponsor":"Astellas Pharma Europe B.V.","startDate":"2015-05","conditions":"Healthy Subjects","enrollment":12},{"nctId":"NCT02279472","phase":"NA","title":"Optical Coherence Tomography Quantitative Analysis of Changes in Anterior Chamber After Laser Peripheral Lridotomy","status":"UNKNOWN","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2014-10","conditions":"Primary Angle Closure Glaucoma","enrollment":40},{"nctId":"NCT01627626","phase":"NA","title":"Effect of 0.1% Pilocarpine Mouthwash on Xerostomia","status":"COMPLETED","sponsor":"Jeong-seong Kwon","startDate":"2011-08","conditions":"Xerostomia","enrollment":60},{"nctId":"NCT00168181","phase":"PHASE3","title":"Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients","status":"COMPLETED","sponsor":"Alberta Health services","startDate":"2002-04","conditions":"Cancer, Head and Neck Cancer","enrollment":220},{"nctId":"NCT01126203","phase":"PHASE3","title":"Randomized Prospective Study of Selective Laser Trabeculoplasty (SLT) Versus Argon Trabeculoplasty (ALT) in Patients With Pseudoexfoliation Glaucoma and Ocular Hypertension","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2006-09","conditions":"Exfoliation Syndrome, Ocular Hypertension","enrollment":25},{"nctId":"NCT00804115","phase":"NA","title":"The International Collaborative Exfoliation Syndrome Treatment Study","status":"UNKNOWN","sponsor":"The New York Eye & Ear Infirmary","startDate":"2000-08","conditions":"Exfoliation Syndrome, Glaucoma, Ocular Hypertension","enrollment":277},{"nctId":"NCT00438048","phase":"PHASE4","title":"A Comparison of Orally Pilocarpine and Artificial Saliva in Xerostomy Treatment","status":"COMPLETED","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2006-11","conditions":"Primary Sjogren, Secondary Sjogren, Xerostomia","enrollment":76},{"nctId":"NCT00624039","phase":"NA","title":"The Effect of Cataract Extraction on the Contractility of Ciliary Muscle","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2006-05","conditions":"Presbyopia, Cataract","enrollment":15}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":65,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["AGN-190584"],"phase":"phase_3","status":"active","brandName":"Pilocarpine HCl","genericName":"Pilocarpine HCl","companyName":"Allergan","companyId":"allergan","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Pilocarpine HCl is a muscarinic acetylcholine receptor agonist that stimulates parasympathetic activity to increase salivary and lacrimal gland secretion. Used for Xerostomia (dry mouth) in patients with Sjögren's syndrome, Xerophthalmia (dry eyes), Radiation-induced xerostomia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}